UNSPSC 51281516: Morinamide hydrochloride

This classification denotes an antitubercular agent C10H14N4O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2F6F46T9YC, chemically known as 2-pyrazinecarboxamide, n-(4-morpholinylmethyl)-, hydrochloride (1:1), but more generally known as morinamide hydrochloride, which bears US NIH Compound Identifier 164837. European Medicines Agency schedules Morinamide hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03330MIG.

Most nations, for tariff and trade purposes, schedule morinamide hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, MORINAMIDE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C1CNC(CN1)C(=O)NCN2CCOCC2.CL.

UNSPSC 51281516 Morinamide hydrochloride is a Commodity code that nominally designates a single pharmaceutical product, yet the recent state and local opportunities tagged under it do not reflect procurement of morinamide itself. Instead, the code appears applied across a broader spectrum of pharmaceutical warehouse and emergency-response drug acquisitions, including antibiotic tablets, opioid-reversal medications, and drug-deactivation systems. State and local health departments and county governments are the primary issuing bodies, sourcing these products through competitive bidding processes and cooperative purchasing vehicles such as MMCAP Infuse. The work involves award of fixed-term supply contracts with renewal options, vendor compliance with drug-free workplace and E-Verify requirements, and quarterly or as-needed delivery to health facilities and emergency-response sites.

Illinois Department of Public Health and Seminole County, Florida both posted opportunities under this code in 2026. Illinois awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC via IFB on August 28, 2026, for Doxycycline Hyclate and Ciprofloxacin Hydrochloride across 12 months plus renewal options. Seminole County issued an IFB on June 30, 2026 (due July 26, 2023 per the record) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida; the procurement included FEMA-potential funding and required vendor compliance with federal environmental and procurement regulations. The code shows activity in the Southeast and Midwest, though the mismatch between the code's nominal scope and the actual products being solicited suggests either broad tagging practice or classifier error within state and local procurement systems.